Dr. Indu Singh is an Assistant Professor in Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India since March 2017. She has also worked as Assistant Professor, in Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar Central University, Lucknow (From August 2016 to March 2017). She possesses Bachelor of Pharmacy degree (B. Pharm.), Master degree (M. Pharm) in Pharmaceutics and Doctorate degree (PhD) in Pharmaceutics (April, 2016). She has done her PhD in the area of Nanomedicines (Bioconjugated nanotherapeutics for tumor targeting) from National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, GOI with AIR 1. She has been a Gold medalist in M. Pharm and Silver medalist in B. Pharm. She was awarded with Sumitra Devi Wahi Memorial Award for best outgoing B. Pharm final year student of the year in 2008. She also got Graduate Aptitude test in Engineering (GATE) scholarship by Ministry of Human Resource Development (MHRD) and Fellowship from Ministry of Chemicals and Fertilizers, GOI for persuing M. Pharm and PhD respectively. She is a registered pharmacist with Pharmacy Council of India; Uttar Pradesh Pharmacy Council, Lucknow (since 2009). She Qualified Women Scientist-C (WOS-C) examinations (KIRAN-IPR) conducted by Department of Science and Technology (DST), New Delhi, India in 2015. She was also awarded with Young Scientist International Travel Grant from Council of Scientific and Industrial Research (CSIR), India to attend 6th International Conference on Nanomaterials - Research & Application, NANOCON-2014 at Brno, Czech Republic, EU. She has several awards to her credit for oral and poster presentation in various national and international conferences. She have successfully supervised three Master degrees, and currently supervising 2 Master degree candidates. She has also published many research papers in peer reviewed journals with good impact factor, author of few book chapters.

Dr. Indu Singh’s research interest includes nanoparticulate assisted delivery approach to deliver therapeutic and biotherapeutic molecules to target site by giving special consideration to size, shape and surface modification of nanostructures (nanoparticles, dendrimers) with bioconjugation for active targeting to the brain and breast cancer.